Take Control Of Your Health | Home Blood Testing Services
Review 4.8 / 55 Stars! Private STI Tests &ampl; Health Checks Online Reviews
Login ›Basket (0)
Basket (0)
Find Your Test
Womens
Mens
All Tests
Conditions
Help

Essential Health Tests Before Your First Weight Loss Shot

‹ Health BlogWellness ›Medical News ›Fitness ›

Do you know a mate who’s mysteriously shed half their wardrobe overnight? Claims they’ve finally stuck to the gym, or 'just cut out bread'? Odds are, they've had a little help — from a GLP-1 weight loss jab.

Over the last couple of years, drugs like Ozempic, Wegovy, and Mounjaro have exploded in popularity - from Hollywood red carpets to your local high street. Originally developed to help manage type 2 diabetes, these medications are now repurposed (and rebranded) to help with weight loss. But before you jump on the bandwagon, there’s something crucial you should know: these drugs aren’t just harmless appetite hacks - they are serious medications with real impacts on your metabolism and beyond.

Let’s break it down.

 

 

What exactly are these weight loss jabs?

These injections are part of a class called GLP-1 receptor agonists. GLP-1 (glucagon-like peptide-1) is a hormone produced naturally in your gut when you eat. It stimulates insulin secretion, suppresses glucagon secretion, slows gastric emptying (making you feel fuller for longer), and acts on appetite centres in the brain to reduce food intake (Holst, 2007).

Pharmaceutical companies, being the clever chemists they are, have harnessed this hormone to develop injectable drugs that essentially mimic or enhance these effects.

 

 

How do they differ? 

Drug Name Active Ingredient Original Use Primary Mechanism Approx. Monthly Cost (UK) Main Weight Loss Action Common Side Effects
Ozempic Semaglutide Type 2 diabetes Mimics GLP-1 to increase insulin, reduce appetite, slow gastric emptying (Wilding et al., 2021) ~£250–£300 Appetite reduction, longer satiety Nausea, vomiting, diarrhoea, constipation, fatigue
Wegovy Higher dose Semaglutide Weight loss Same as Ozempic but higher dose for obesity management (Wilding et al., 2021) ~£300–£500 Strong appetite suppression, full signal amplification Similar to Ozempic but more pronounced GI effects
Mounjaro Tirzepatide Type 2 diabetes Dual action: mimics GLP-1 and GIP, increases insulin, reduces appetite, improves insulin sensitivity (Frías et al., 2021) ~£500–£800 Appetite suppression, improved insulin sensitivity Nausea, diarrhoea, possible gallbladder issues
Saxenda Liraglutide Type 2 diabetes GLP-1 mimetic, daily injection (Davies et al., 2015) ~£250–£400 Reduced appetite, slower digestion GI issues, potential pancreatitis

*Costs are approximate and vary depending on pharmacy, provider, and availability.

 

 

Why were these drugs originally for diabetics?

GLP-1 receptor agonists were first developed to improve glycaemic control in type 2 diabetes patients. They help stimulate insulin secretion in a glucose-dependent manner and reduce inappropriate glucagon secretion, thereby lowering blood glucose levels (Drucker & Nauck, 2006).

Patients also showed unexpected weight loss during trials, leading to further studies and eventual approval for obesity treatment (Wilding et al., 2021).

Basically: Weight loss was initially a happy side effect observed in diabetic patients - so, naturally, pharma companies saw a shiny new market and ran with it.

 

Why is this a big deal if you're not diabetic?

When you tinker with hormones like insulin and GLP-1, you're essentially messing with your metabolic orchestra. For diabetics, these drugs help correct an existing imbalance. For non-diabetics, you’re introducing a powerful metabolic shift that can have unintended consequences.

 

Key reasons to be cautious:

  • Pancreas stress: You might push your insulin production or suppression beyond what’s naturally safe. Altered insulin dynamics can stress pancreatic beta cells (Garber et al., 2020).
  • Nutritional deficiencies: If you're eating less and absorbing differently, vitamin and mineral deficiencies can creep in - think B12, iron, or vitamin D (Khalil et al., 2021).
  • Gallbladder risks: Rapid weight loss can increase gallstone formation (Sjölund et al., 2014).
  • Thyroid impact: Some studies suggest links to thyroid C-cell tumours. Rodent studies have linked GLP-1 agonists to C-cell thyroid tumours; human risk remains low but remains monitored (Marso et al., 2016).

 

 

Essential lab tests before your first jab

Before you sign up for the weekly prick, you should know exactly what’s going on inside your body. After all, you wouldn’t start driving a supercar without checking the oil, would you?

  • HbA1c (long-term blood sugar) - Checks for undiagnosed diabetes or prediabetes.
  • Liver function tests — These drugs can strain your liver, especially with rapid weight loss.
  • Kidney function — GLP-1 drugs can affect kidney filtration rates.
  • Thyroid function (TSH, T3, T4) — Important to establish baseline health and monitor any potential effects.
  • Vitamin and minerals panel — Check B12, iron, vitamin D, and other key nutrients to ensure you’re not already running low.
  • Cholesterol / Lipid profile — Rapid fat loss can transiently affect cholesterol levels.

 

 

Other drugs that contain similar mechanisms

It's worth repeating that GLP-1 agonists aren’t just found in weight loss injections. They’re a backbone therapy in type 2 diabetes (Ozempic, Mounjaro, Victoza, etc.), sometimes combined with other antidiabetic agents. It is worth noting that their original job was never to melt away beach weight - it was to save lives by regulating glucose.

 

 

The social side: are we just "cheating"?

You might hear chatter like: “They’re just taking the easy way out!”

Well, that’s a debate for another day. But regardless of how one feels about using these meds for weight loss, the bottom line remains: you owe it to yourself (and your future pancreas) to know your baseline health first.

 

 

Final thoughts

Weight loss jabs might look like a magic bullet, but they’re actually a metabolic sledgehammer, creating hormonal havoc. Taking them without understanding your body’s current state is like renovating your house without checking the foundation - risky business.

What if we told you that you could know exactly what’s happening inside your body in just 48 hours? With comprehensive at-home tests covering everything from glucose levels to vitamins and hormones, you’ll have the full picture before making any big changes.

 

Get Yourself Tested With Vitall's Home Test Kits

Health is in your hands
Health is in your hands
Take Control Of Your Health | Home Blood Testing Services

Vitamins & Minerals Complete Test Kit

Vitamins & Minerals Complete test kit
Vitamins & Minerals Complete Home Test Kit UK

Vitamins & Minerals Complete Test Kit

Fully identify & optimise nutritional deficiencies

£99.00

View Full Details ›
Health is in your hands
Health is in your hands
Take Control Of Your Health | Home Blood Testing Services

Damage Control Test Kit

Damage Control test kit
Damage Control Home Test Kit UK

Damage Control Test Kit

Target the big three lifestyle risk factors - diabetes, heart disease and liver disease

£109.00

View Full Details ›
Health is in your hands
Health is in your hands
Take Control Of Your Health | Home Blood Testing Services

Kidney Function Test Kit

Kidney Function test kit
Kidney Function Home Test Kit UK

Kidney Function Test Kit

Assess normal kidney function and your electolytes

£199.00

View Full Details ›

Article Reviewed By

Doctors, Scientists & Experts Delivering Private Blood Testing Online

Ben Starling MSc. |Commercial Director

Ben joins us with over 20 years of industry experience in clinical diagnostics. With a degree in Medical Biochemistry and a masters in Toxicology, Ben founded Vitall in order to address the growing need for preventive healthcare in an increasingly unhealthy population.

More Articles in These Categories

Health BlogWellnessMedical NewsFitness

Similar Articles

View all articles ›

Discover Hederasaponin C: A New Hope for Combating Diabetic Kidney Disease

›

Kidney Check! Why Monitoring Your Electrolytes Could Save Your Life

›

Is Your Lifestyle Destroying Your Kidneys? Find Out Before It’s Too Late

›

Why Salt is The Most Misunderstood Mineral on Earth

›

Why Food Matters More on GLP-1s Than Most People Expect

›

How Nutritional Deficiencies Impact Anxiety and Mental Health

›

UK Statistics On Vitamin & Mineral Deficiency 2023

›

Vitamin B12 Deficiency–Causes And Symptoms

›

The Role of Vitamins and Minerals in Immune Function

›

How Important is Calcium?

›
View all articles ›

References & Citations For Essential Health Tests Before Your First Weight Loss Shot

  • American Diabetes Association (ADA). (2022). Standards of Medical Care in Diabetes—2022. Diabetes Care, 45(Suppl 1): S1–S264.

  • Blundell, J., Finlayson, G., Axelsen, M., Flint, A., & Gibbons, C. (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 19(9), 1242-1251.

  • Davies, M. J., Bergenstal, R., Bode, B., et al. (2015). Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE Diabetes randomized clinical trial. JAMA, 314(7), 687-699.

  • Drucker, D. J., & Nauck, M. A. (2006). The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. The Lancet, 368(9548), 1696-1705.

  • Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515.

  • Garber, A. J., Handelsman, Y., Grunberger, G., et al. (2020). Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2020 executive summary. Endocrine Practice, 26(1), 107-139.

  • Holst, J. J. (2007). The physiology of glucagon-like peptide 1. Physiological Reviews, 87(4), 1409-1439.

  • Khalil, A. A., Mohktar, M. S., Sulaiman, S. A., & Ibrahim, F. (2021). The impact of GLP-1 receptor agonists on nutrient intake and nutritional status. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(4), 102200.

  • Marso, S. P., Bain, S. C., Consoli, A., et al. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 375(19), 1834-1844.

  • Müller, N., Dicker, D., Atkin, S., & Tsapas, A. (2019). Effects of GLP-1 receptor agonists on renal outcomes in type 2 diabetes: an updated meta-analysis. Diabetes Research and Clinical Practice, 155, 107804.

  • Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22.

  • Sjölund, K., Torgerson, J. S., & Carlsson, L. M. S. (2014). Gallstone disease and its association with weight loss: results from a randomized controlled trial of obesity treatment. American Journal of Gastroenterology, 109(8), 1222-1229.

  • Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.

Useful links

About VitallContact UsHelp CentreClinic LocationsBiomarkersHealth BlogPartnershipsEmployee HealthOur Terms
Facebook Icon for VitallInstagram Icon for VitallLinkedIn Icon for VitallPinterest Icon for VitallTiktok Icon for Vitall

Join our mailing list for 10% off!

Popular tests

Female FertilityFemale Total Health CheckFull Blood CountMale Total Health CheckTestosterone & EstrogenVitamins & Minerals
All Tests Are CE marked, IVDAll Tests Are CE marked, IVDUKAS Quality Management  Expert Blood Test Analysis in an Accredited Laboratory

All Testing Is Conducted In UKAS Accredited Laboratories.

© 2026 Healthy Human Labs LTD, 71 - 75 Shelton Street, Covent Garden, London, WC2H 9JQ.

Vitall AI Chat